BlackRock Investment Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.8M | Buy |
259,023
+40,344
| +18% | +$436K | ﹤0.01% | 1987 |
|
|
2016
Q3 | $2.24M | Sell |
218,679
-374
| -0.2% | -$3.83K | ﹤0.01% | 2057 |
|
|
2016
Q2 | $2.86M | Buy |
219,053
+42,382
| +24% | +$554K | ﹤0.01% | 1846 |
|
|
2016
Q1 | $1.94M | Buy |
176,671
+2,896
| +2% | +$31.9K | ﹤0.01% | 2030 |
|
|
2015
Q4 | $1.6M | Sell |
173,775
-18
| -0% | -$166 | ﹤0.01% | 2243 |
|
|
2015
Q3 | $1.21M | Sell |
173,793
-4,642
| -3% | -$32.2K | ﹤0.01% | 2461 |
|
|
2015
Q2 | $1.75M | Buy |
178,435
+19,777
| +12% | +$194K | ﹤0.01% | 2351 |
|
|
2015
Q1 | $1.41M | Buy |
158,658
+1,682
| +1% | +$14.9K | ﹤0.01% | 2282 |
|
|
2014
Q4 | $1.38M | Sell |
156,976
-825
| -0.5% | -$7.23K | ﹤0.01% | 2323 |
|
|
2014
Q3 | $1.09M | Sell |
157,801
-192
| -0.1% | -$1.32K | ﹤0.01% | 2462 |
|
|
2014
Q2 | $831K | Sell |
157,993
-2,904
| -2% | -$15.3K | ﹤0.01% | 2726 |
|
|
2014
Q1 | $732K | Buy |
160,897
+2,174
| +1% | +$9.89K | ﹤0.01% | 2719 |
|
|
2013
Q4 | $800K | Sell |
158,723
-3,381
| -2% | -$17K | ﹤0.01% | 2647 |
|
|
2013
Q3 | $822K | Buy |
162,104
+4,476
| +3% | +$22.7K | ﹤0.01% | 2574 |
|
|
2013
Q2 | $782K | Buy |
+157,628
| New | +$782K | ﹤0.01% | 2537 |
|